SmileDirectClub Inc

SmileDirectClub Inc

  • Price (USD)0.381
  • Today's Change0.026 / 7.29%
  • Shares traded1.45m
  • 1 Year change-71.99%
  • Beta2.1128
Data delayed at least 15 minutes, as of Jun 01 2023 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SmileDirectClub, Inc.is an oral care company and creator of the first medtech platform for teeth straightening. Through its cutting-edge teledentistry technology and vertically integrated model, it provides clear aligner therapy and premium oral care product line. The Company’s clear aligner treatment addresses the orthodontics market. The Company offers a suite of oral care products, such as whitening kits, toothbrushes, toothpaste, and other ancillary oral care products. The Company also offers oral care market products, such as retainers, toothbrushes, toothpaste, water flosser, SmileSpa, lip balm, MoveMints, BrightOn premium whitening, and a light-emitting diode (LED) accelerator light. Its platform supports its customers and their treating doctors, and the clinical and customer care teams. It has a network of over 125 SmileShops in the locations, as well as partnerships with over 1,000 dental practices. It also has a network of over 200 orthodontists and general dentists.

  • Revenue in USD (TTM)438.87m
  • Net income in USD-85.24m
  • Incorporated2019
  • Employees2.70k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Eargo Inc39.89m-148.76m101.01m243.00--1.23--2.53-47.63-47.634.613.970.3194.555.63164,135.80-118.99-78.64-201.12-107.3939.3656.30-372.98-189.353.71-2.380.00---44.0141.270.1693--52.93--
DarioHealth Corp26.66m-60.29m105.45m241.00--1.44--3.95-2.49-2.491.082.780.22662.437.23110,634.90-50.23-85.72-57.77-104.6233.1528.99-221.66-288.462.76-79.860.2602--34.8239.8518.95--24.06--
Viewray Inc105.86m-110.42m106.56m295.00--1.93--1.01-0.6089-0.60890.58380.30130.39862.312.80358,861.00-41.57-36.45-77.52-
Neuropace Inc48.62m-46.00m111.78m167.00--4.06--2.30-1.86-1.861.961.080.41331.495.33291,125.80-39.10---43.12--71.18---94.61--8.04-7.160.6621--0.7459---30.49------
Fonar Corp97.68m9.75m117.65m484.0012.250.74866.731.201.391.3913.8822.710.494620.701.47201,820.606.8911.497.2112.9446.7148.8013.9220.048.57--0.0069--8.524.5721.88-8.669.04--
Hyperfine Inc7.94m-61.55m120.83m136.00--1.07--15.22-0.8726-0.87260.11251.590.05281.163.2058,382.35-40.91---43.73--24.91---775.18--13.92--0.00--355.48---12.82------
Asensus Surgical Inc7.00m-78.65m129.31m183.00--1.62--18.48-0.3317-0.33170.02950.33310.05321.3311.7838,234.97-59.79-54.24-64.59-60.13-71.44-25.25-1,124.07-808.405.77--0.00---13.91-0.0676-20.97---8.47--
Cytosorbents Corp35.45m-31.17m131.86m198.00--4.54--3.72-0.7148-0.71480.81260.66030.50374.377.02179,024.60-44.30-35.71-53.92-43.2355.7969.39-87.94-61.142.53-60.750.1475---19.6418.02-33.61--30.92--
Perspective Therapeutics Inc8.97m-10.39m147.94m66.00--1.36--16.50-0.0732-0.07320.06310.38710.14294.311.97135,863.60-16.56-19.32-17.15-20.5435.5145.13-115.91-59.2920.81------7.3817.79-114.51---15.85--
SmileDirectClub Inc438.87m-85.24m152.25m2.70k--1.54--0.3469-0.6895-0.68953.550.24660.69893.362.77162,545.90-43.06-43.59-28.82-47.3969.7671.43-61.61-51.201.88-9.662.06---26.1726.3915.66--38.98--
Beyond Air Inc0.00-55.65m159.15m70.00--3.12-----1.87-1.870.001.700.00----0.00-68.00---81.14----------5.61-60.760.0036---100.00---88.75------
KORU Medical Systems Inc29.04m-8.53m167.40m85.00--5.61--5.76-0.1888-0.18880.64250.65430.71122.087.95341,697.90-20.90-9.86-23.56-11.3054.7260.08-29.38-11.174.11--0.0225--18.76---89.82------
Stereotaxis Inc27.66m-20.90m183.14m130.00--7.19--6.62-0.2742-0.27420.36290.39030.51151.535.78212,753.80-36.16-19.06-47.47-28.8362.9972.32-70.69-27.112.27--0.00---19.63-2.00-62.80--96.30--
InfuSystem Holdings Inc113.52m62.00k183.36m420.005,688.313.8013.761.620.00150.00155.212.311.1310.676.55270,288.100.06194.510.07185.6755.2758.520.05464.161.601.290.4299--7.369.11-98.73--38.60--
Clearpoint Neuro Inc20.95m-18.09m189.04m108.00--5.80--9.02-0.7408-0.74080.85861.330.37410.96098.52194,009.30-32.29-32.98-35.46-37.8964.3767.76-86.31-72.285.98--0.2332--26.0922.73-14.05--112.02--
Semler Scientific Inc60.88m15.93m189.38m127.0013.713.0311.383.,338.6025.3545.3528.7254.4192.5290.0826.1732.416.18--0.00--6.9035.41-16.82--17.34--
Data as of Jun 01 2023. Currency figures normalised to SmileDirectClub Inc's reporting currency: US Dollar USD

Institutional shareholders

11.24%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 20235.29m4.04%
Prentice Capital Management LPas of 31 Mar 20232.40m1.83%
GSA Capital Partners LLPas of 31 Mar 20231.88m1.43%
BlackRock Fund Advisorsas of 31 Mar 20231.47m1.12%
Geode Capital Management LLCas of 31 Mar 20231.12m0.86%
Citigroup Global Markets, Inc. (Broker)as of 31 Mar 2023869.81k0.66%
Morgan Stanley & Co. LLCas of 31 Mar 2023481.07k0.37%
Stephens Investment Management Group LLCas of 31 Mar 2023444.17k0.34%
DWS Investment GmbHas of 31 Mar 2023414.13k0.32%
UBS Securities LLCas of 31 Mar 2023360.40k0.28%
More ▼
Data from 31 Mar 2023 - 31 Mar 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.